Craft

PetLife Pharmaceuticals

Stock Price

$0

2022-08-02

Market Capitalization

$7.9 M

2022-08-02

PetLife Pharmaceuticals Summary

Company Summary

Overview
PetLife Pharmaceuticals is a registered U.S. Veterinary Pharmaceutical company whose mission is to bring its scientifically proven, bioactive medication and nutraceuticals to the world of veterinary oncology. The Company specializes in the research, development, sales and support of advanced drugs and nutraceuticals for pet cancer and autoimmune related diseases such as arthritis.
Type
Public
Status
Closed
Founded
2016
HQ
Hancock, MD, US | view all locations
Website
http://www.petlifepharma.com/
Cybersecurity rating
Sectors

Key People

  • Ralph Salvagno, CEO and Chairman of the Board

    • Vivek Ramana, Chief Medical Officer

      • Clifford Price, VP of Marketing

        • Vyvyan Campbell, Director

          LocationsView all

          1 location detected

          • Hancock, MD HQ

            United States

            38 W Main St

          PetLife Pharmaceuticals Financials

          Summary Financials

          Net income (Q2, 2018)
          ($427.1K)
          Cash (Q2, 2018)
          $7.9K
          EBIT (Q2, 2018)
          ($182.7K)
          Enterprise value
          $8.7M

          Footer menu